Matches in Wikidata for { <http://www.wikidata.org/entity/Q92869308> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q92869308 description "artikull shkencor i botuar më 01 janar 2019" @default.
- Q92869308 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q92869308 description "im Jahr 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92869308 description "scientific article published on 01 January 2019" @default.
- Q92869308 description "wetenschappelijk artikel" @default.
- Q92869308 description "наукова стаття, опублікована 1 січня 2019" @default.
- Q92869308 name "Why are there Variations in the Responses of Glucagon-like Peptide-1 Agonists among the Type 2 Diabetic Patients?" @default.
- Q92869308 name "Why are there Variations in the Responses of Glucagon-like Peptide-1 Agonists among the Type 2 Diabetic Patients?" @default.
- Q92869308 name "Why are there Variations in the Responses of Glucagon-like Peptide-1 Agonists among the Type 2 Diabetic Patients?" @default.
- Q92869308 type Item @default.
- Q92869308 label "Why are there Variations in the Responses of Glucagon-like Peptide-1 Agonists among the Type 2 Diabetic Patients?" @default.
- Q92869308 label "Why are there Variations in the Responses of Glucagon-like Peptide-1 Agonists among the Type 2 Diabetic Patients?" @default.
- Q92869308 label "Why are there Variations in the Responses of Glucagon-like Peptide-1 Agonists among the Type 2 Diabetic Patients?" @default.
- Q92869308 prefLabel "Why are there Variations in the Responses of Glucagon-like Peptide-1 Agonists among the Type 2 Diabetic Patients?" @default.
- Q92869308 prefLabel "Why are there Variations in the Responses of Glucagon-like Peptide-1 Agonists among the Type 2 Diabetic Patients?" @default.
- Q92869308 prefLabel "Why are there Variations in the Responses of Glucagon-like Peptide-1 Agonists among the Type 2 Diabetic Patients?" @default.
- Q92869308 P1433 Q92869308-9B032645-22BE-4239-96E7-1239A5CE7FD4 @default.
- Q92869308 P1476 Q92869308-D0463CC2-829F-410A-BC0E-8BFCA6CA920C @default.
- Q92869308 P2093 Q92869308-DFD0E743-AC50-45B1-9B44-46F379E4FC1A @default.
- Q92869308 P304 Q92869308-3D96022B-5A53-4573-86E7-9803E61FA327 @default.
- Q92869308 P31 Q92869308-DCD8A09C-5693-4BE4-B6E4-EDF5712A7006 @default.
- Q92869308 P356 Q92869308-DA438900-16BB-4D8D-B119-A0C46101913C @default.
- Q92869308 P433 Q92869308-BEAE2005-7314-42FD-AC4B-FEDB49138D2E @default.
- Q92869308 P478 Q92869308-98AE5FE0-8CAE-4285-B10F-DEE9A9789DC4 @default.
- Q92869308 P577 Q92869308-F64CB651-38E0-43EE-AC0A-00C831FA9AA8 @default.
- Q92869308 P698 Q92869308-07837CBD-9824-4DE4-A052-393A950A7D8F @default.
- Q92869308 P356 157488471403191231143537 @default.
- Q92869308 P698 31971106 @default.
- Q92869308 P1433 Q15758043 @default.
- Q92869308 P1476 "Why are there Variations in the Responses of Glucagon-like Peptide-1 Agonists among the Type 2 Diabetic Patients?" @default.
- Q92869308 P2093 "Thekkuttuparambil A Ajith" @default.
- Q92869308 P304 "247-248" @default.
- Q92869308 P31 Q13442814 @default.
- Q92869308 P356 "10.2174/157488471403191231143537" @default.
- Q92869308 P433 "3" @default.
- Q92869308 P478 "14" @default.
- Q92869308 P577 "2019-01-01T00:00:00Z" @default.
- Q92869308 P698 "31971106" @default.